IP Library Patent Application 17148427
Patent Application
App. No. 17/148,427

METHODS AND DEVICES FOR IN SITU FORMED NERVE CAP WITH RAPID RELEASE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/148,427
Abstract

Disclosed are methods, devices and materials for the in situ formation of an implant for treating a nerve. A treatment site on a nerve is positioned within a cavity defined by a form. A transformable media is introduced into the form cavity to surround the treatment site. The media is permitted to undergo a transformation from a first, relatively flowable state to a second, relatively non flowable state to form a protective barrier surrounding the treatment site. A hydrophilic characteristic of the media cooperates with a hydrophobic characteristic of the surface of the cavity to facilitate a rapid release of the implant from the cavity following the transformation. The implant may be a growth inhibiting nerve cap to inhibit neuroma formation following planned or traumatic nerve injury, a growth permissive conduit for facilitating reconnection of a severed nerve, or an anchor for stabilizing a pain management electrode with respect to a nerve. Access to the nerve treatment site may be open surgical or percutaneous.

Claims (36)

1 . A method of in situ formation of an implant, comprising the steps of:

identifying a nerve;

positioning the nerve in a cavity defined by a form;

introducing media into the cavity to surround the nerve; and

permitting the media to undergo a transformation from a first, relatively flowable state to a second, relatively non flowable state to form a protective barrier surrounding the nerve;

wherein a hydrophilic characteristic of the media cooperates with a hydrophobic characteristic of the cavity to facilitate a rapid release of the implant from the cavity following the transformation.

2 . The method of in situ formation as in claim 1 , comprising positioning a severed end of a nerve into the cavity, and permitting the media to undergo a transformation state to form a protective barrier surrounding the severed end of the nerve.

3 . The method of in situ formation as in claim 1 , wherein the implant can be removed from the cavity by a pull force of no more than about 10 N, applied for no more than about 5 seconds.

4 . The method of in situ formation as in claim 1 , wherein the implant can be removed from the cavity by a pull force of no more than about 5 N.

5 . The method of in situ formation as in claim 1 , wherein the implant can be removed from the cavity by a pull force of no more than about 2 N applied for no more than about 2 seconds.

6 . The method of in situ formation as in claim 1 , wherein the implant can be removed from the cavity within about 2 seconds, without disrupting attachment between the implant and the nerve.

7 . The method of in situ formation as in claim 1 , wherein the in situ formation occurs through chemical or photo crosslinking.

8 . The method of in situ formation as in claim 1 , wherein the introducing media step includes introducing a first volume of media, and following transformation of the first volume, introducing a second volume of media.

9 . A method of in situ formation of an implant, comprising the steps of:

identifying an implant formation site;

positioning a form having an implant cavity at the site;

introducing media into the cavity to form an implant precursor; and

permitting the media to undergo a transformation from a first, relatively flowable state to a second, relatively non flowable state to form the implant;

wherein a hydrophilic characteristic of the media cooperates with a hydrophobic characteristic of the cavity to facilitate a rapid release of the implant from the cavity following the transformation.

10 . The method of in situ formation as in claim 9 , wherein the implant is a nerve cap for inhibiting neuroma formation around a severed nerve end.

11 . The method of in situ formation as in claim 9 , wherein the implant is a nerve conduit for guiding growth of a nerve.

12 . The method of in situ formation as in claim 9 , wherein the implant is a nerve wrap for preventing scar tissue-related nerve compression and nerve tethering.

13 . The method of in situ formation as in claim 9 , wherein the implant reduces the incidence or persistence of chronic pain.

14 . The method of in situ formation as in claim 9 , wherein the implant is a tissue bulking implant.

15 . The method of in situ formation as in claim 9 , wherein the implant is a vascular occlusion device.

16 . The method of in situ formation as in claim 9 , wherein the implant is a tendon repair device.

17 . A method of in situ formation of a nerve cap, comprising the steps of:

identifying a severed end of a nerve;

positioning the severed end into a cavity defined by a form;

introducing media into the cavity to surround the severed end; and

permitting the media to undergo a transformation from a first, relatively flowable state to a second, relatively non flowable state to form a protective barrier surrounding the severed nerve end;

wherein a hydrophilic characteristic of the media cooperates with a hydrophobic characteristic of the cavity to facilitate a rapid release of the nerve cap from the cavity following the transformation.

18 . A method of in situ formation of a nerve cap as in claim 17 , further comprising the step of removing the form.

19 . A method of in situ formation of a nerve cap as in claim 17 , comprising identifying a surgically or traumatically severed nerve.

20 . A method of in situ formation of a nerve cap as in claim 17 , wherein the form comprises a nerve guide, and said positioning step comprises positioning the nerve such that the nerve guide maintains the severed end within the cavity spaced apart from a sidewall of the form.

21 .- 99 . (canceled)

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2023
From: BRIGHT, CORINNE; REN, YONG; MARTIN, KEN
To: TULAVI THERAPEUTICS, INC.
Reel/Frame 063620/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2023
From: KHOSRAVI, FARHAD; SAWHNEY, AMARPREET S.
To: INCEPT, LLC
Reel/Frame 063620/0162 →
CHANGE OF ADDRESS Recorded Jul 26, 2022
From: TULAVI THERAPEUTICS, INC.
To: TULAVI THERAPEUTICS, INC.
Reel/Frame 060920/0833 →